annual EBIT:
-$177.70M+$71.03M(+28.56%)Summary
- As of today (May 25, 2025), TXG annual earnings before interest & taxes is -$177.70 million, with the most recent change of +$71.03 million (+28.56%) on December 31, 2024.
- During the last 3 years, TXG annual EBIT has fallen by -$124.85 million (-236.23%).
- TXG annual EBIT is now -891.05% below its all-time high of -$17.93 million, reached on December 31, 2017.
Performance
TXG EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$33.51M+$14.87M(+30.74%)Summary
- As of today (May 25, 2025), TXG quarterly earnings before interest & taxes is -$33.51 million, with the most recent change of +$14.87 million (+30.74%) on March 31, 2025.
- Over the past year, TXG quarterly EBIT has increased by +$24.30 million (+42.03%).
- TXG quarterly EBIT is now -1048.25% below its all-time high of -$2.92 million, reached on March 31, 2019.
Performance
TXG quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$153.40M+$24.30M(+13.67%)Summary
- As of today (May 25, 2025), TXG TTM earnings before interest & taxes is -$153.40 million, with the most recent change of +$24.30 million (+13.67%) on March 31, 2025.
- Over the past year, TXG TTM EBIT has increased by +$103.50 million (+40.29%).
- TXG TTM EBIT is now -945.67% below its all-time high of -$14.67 million, reached on September 30, 2018.
Performance
TXG TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TXG EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.6% | +42.0% | +40.3% |
| 3 y3 years | -236.2% | +19.4% | -83.7% |
| 5 y5 years | -535.7% | -66.0% | -239.2% |
TXG EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -236.2% | +28.6% | -105.7% | +63.5% | -83.7% | +40.3% |
| 5 y | 5-year | -535.7% | +66.7% | -243.7% | +91.8% | -239.2% | +71.2% |
| alltime | all time | -891.0% | +66.7% | -1048.3% | +91.8% | -945.7% | +71.2% |
TXG EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$33.51M(-30.7%) | -$153.40M(-13.7%) |
| Dec 2024 | -$177.70M(-28.6%) | -$48.38M(+40.5%) | -$177.70M(+1.0%) |
| Sep 2024 | - | -$34.44M(-7.1%) | -$175.91M(-24.6%) |
| Jun 2024 | - | -$37.08M(-35.9%) | -$233.21M(-9.2%) |
| Mar 2024 | - | -$57.80M(+24.1%) | -$256.90M(+3.3%) |
| Dec 2023 | -$248.73M(+54.0%) | -$46.59M(-49.2%) | -$248.73M(+13.9%) |
| Sep 2023 | - | -$91.74M(+51.0%) | -$218.43M(+31.1%) |
| Jun 2023 | - | -$60.76M(+22.4%) | -$166.60M(-1.7%) |
| Mar 2023 | - | -$49.63M(+204.8%) | -$169.56M(+5.0%) |
| Dec 2022 | -$161.50M(+205.6%) | -$16.29M(-59.2%) | -$161.50M(+0.3%) |
| Sep 2022 | - | -$39.92M(-37.4%) | -$160.99M(+17.1%) |
| Jun 2022 | - | -$63.72M(+53.3%) | -$137.49M(+64.6%) |
| Mar 2022 | - | -$41.57M(+163.5%) | -$83.52M(+58.0%) |
| Dec 2021 | -$52.85M | -$15.78M(-4.0%) | -$52.85M(-88.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$16.43M(+68.5%) | -$445.38M(-9.8%) |
| Jun 2021 | - | -$9.75M(-10.5%) | -$493.82M(-5.7%) |
| Mar 2021 | - | -$10.89M(-97.3%) | -$523.51M(-1.7%) |
| Dec 2020 | -$532.79M(+1806.0%) | -$408.31M(+529.5%) | -$532.79M(+308.2%) |
| Sep 2020 | - | -$64.87M(+64.5%) | -$130.52M(+75.1%) |
| Jun 2020 | - | -$39.44M(+95.4%) | -$74.54M(+64.8%) |
| Mar 2020 | - | -$20.18M(+234.5%) | -$45.22M(+61.8%) |
| Dec 2019 | -$27.95M(-74.6%) | -$6.03M(-32.1%) | -$27.95M(-71.1%) |
| Sep 2019 | - | -$8.89M(-12.1%) | -$96.71M(-5.6%) |
| Jun 2019 | - | -$10.12M(+246.6%) | -$102.50M(+10.9%) |
| Mar 2019 | - | -$2.92M(-96.1%) | -$92.38M(+3.3%) |
| Dec 2018 | -$109.99M(+513.4%) | -$74.79M(+409.8%) | -$89.46M(+509.8%) |
| Sep 2018 | - | -$14.67M | -$14.67M |
| Dec 2017 | -$17.93M | - | - |
FAQ
- What is 10x Genomics annual earnings before interest & taxes?
- What is the all time high annual EBIT for 10x Genomics?
- What is 10x Genomics annual EBIT year-on-year change?
- What is 10x Genomics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for 10x Genomics?
- What is 10x Genomics quarterly EBIT year-on-year change?
- What is 10x Genomics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for 10x Genomics?
- What is 10x Genomics TTM EBIT year-on-year change?
What is 10x Genomics annual earnings before interest & taxes?
The current annual EBIT of TXG is -$177.70M
What is the all time high annual EBIT for 10x Genomics?
10x Genomics all-time high annual earnings before interest & taxes is -$17.93M
What is 10x Genomics annual EBIT year-on-year change?
Over the past year, TXG annual earnings before interest & taxes has changed by +$71.03M (+28.56%)
What is 10x Genomics quarterly earnings before interest & taxes?
The current quarterly EBIT of TXG is -$33.51M
What is the all time high quarterly EBIT for 10x Genomics?
10x Genomics all-time high quarterly earnings before interest & taxes is -$2.92M
What is 10x Genomics quarterly EBIT year-on-year change?
Over the past year, TXG quarterly earnings before interest & taxes has changed by +$24.30M (+42.03%)
What is 10x Genomics TTM earnings before interest & taxes?
The current TTM EBIT of TXG is -$153.40M
What is the all time high TTM EBIT for 10x Genomics?
10x Genomics all-time high TTM earnings before interest & taxes is -$14.67M
What is 10x Genomics TTM EBIT year-on-year change?
Over the past year, TXG TTM earnings before interest & taxes has changed by +$103.50M (+40.29%)